Contact
William H. Frishman, M.D., is an internist and cardiologist with a research interest in cardiovascular pharmacology, clinical epidemiology, and geriatrics. Dr. Frishman has authored and co-authored more than 900 original articles, reviews, and book chapters. He has also edited, co-edited, authored, and co-authored twelve full-length textbooks, including the major text Cardiovascular Pharmacotherapeutics (McGraw-Hill), now in its second edition. Dr. Frishman published three books: Complementary and Integrative Therapies for Cardiovascular Disease (Elsevier 2005), Cardiovascular Regeneration and Stem Cell Therapy (Blackwell Futura, 2007), and Hypertension: A Clinical Guide (Lippincott, 2007). He is also the supplements editor for the American Journal of Medicine and a co-editor of the journal Cardiology in Review and the Yearbook of Medicine.
Education
- M.D., Boston University School of Medicine
Areas of Expertise
- Cardiovascular Pharmacology
- Clinical Epidemiology
- Geriatrics
Honors and Awards
- Teaching Scholar Award of the American Heart Association
- Preventative Cardiology Academic Award from the National Heart, Lung and Blood Institute
- Distinguished Teacher Award, Alpha Omega Alpha National Medical Honor Society
Research
Dr. Frishman has served as a principal investigator in multiple NIH-funded studies, including the "Systolic Hypertension in the Elderly" (SHEP) Trial, the "Studies of Left Ventricular Dysfunction" (SOLVD), the "Women's Health Initiative Trial" (WHI), and the "Bronx Longitudinal Aging Study."
Publications
- Khalid H, Kim A, Lau T, et. al. "Lactation Safety in Peripartum Cardiomyopathy." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001258
- Neshat N, Frishman WH, Aronow WS, et. al. "Caffeine and Cardiovascular Outcomes: Current Evidence and Clinical Perspectives." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001252
- AlSejari NY, Gadelmawla AF, Alfehaid A, et. al. "Sacubitril/Valsartan Versus Enalapril in Chagas Cardiomyopathy With Heart Failure: A Systematic Review and Meta-Analysis." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001270
- Thukral J, Moudgil P, Sindhwani N, et. al. "Cancer-Associated Takotsubo Syndrome: An Emerging Intersection of Cardio-Oncology." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001269
- Adrejiya P, Neshat N, Patel A, et. al. "Artificial Intelligence-Enabled Prediction of Reversible Versus Irreversible Chemotherapy-Induced Myocardial Injury: Toward Precision Cardio-Oncology." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001268
- Thukral J, Moudgil P, Sindhwani N, et. al. "Clonal Cytopenias of Undetermined Significance and Cardiovascular Disease: Inflammatory Mechanisms, Risk Stratification, and Clinical Outcomes." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001267
- Kaiser ME, Farmer BM, Parikh MA, et. al. "Genetically Modified Foods: Have They Reduced Cardiovascular Risk?" Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001226
